Cytokinetics board
WebMar 29, 2024 · Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments ... WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 AM Eastern …
Cytokinetics board
Did you know?
WebOct 15, 2024 · Oct. 15, 2024, 7:18 AM PDT. By Minyvonne Burke. A high school student in Loudoun County, Virginia, who was charged with sexually assaulting a female at one … WebCytokinetics, Incorporated (NASDAQ: CYTK) announced today the resignation of Michael Schmertzler from the company's Board of Mr. 2003. Contemporaneously with Mr. Schmertzler's resignation, the Board of Directors has elected Santo J. Costa to the company's Board. Both of these changes are effective immediately.
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. Investor Overview Stock … WebCYTOKINETICS, INCORPORATED 2004 EQUITY INCENTIVE PLAN, AS AMENDED (As amended by the Board of Directors on February 6, 2013; Stockholder approval May 22, 2013; updated following reverse stock split June 25, 2013) from Cytokinetics, Incorporated filed with the Securities and Exchange Commission.
WebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced changes to its Board of Directors. … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & …
WebFeb 17, 2024 · For the three months ended September 30, 2024, Cytokinetics reported a net loss of $142.3 million, or $1.52 per share, compared to a net loss of $76.1 million, or $0.95 per share, for the same ...
WebApr 6, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology … daniel lissing net worth currentlyWebFeb 12, 2024 · Former FDA Commissioner Robert Califf is joining yet another San Francisco company’s board. Less than a year after accepting a board seat at Alphabet’s Verily, Califf is... daniel lissing in when hope callsWebThis Amendment No. 6 to the Agreement (this “Amendment No. 6”) is entered into as of June 11, 2013 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a ... daniel lissing leaves when calls the heartWebApr 7, 2024 · SOUTH SAN FRANCISCO, CA, Mar 07, 2012 (MARKETWIRE via COMTEX) --Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the resignation of … daniel lissing great american familyWebApr 1, 2024 · SOUTH SAN FRANCISCO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate ... daniel lissing hallmark christmas movieWebDec 31, 2024 · CYTOKINETICS, INCORPORATED (Exact name of registrant as specified in its charter) (650) 624-3000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12 (b) of the Act: Securities registered pursuant to Section 12 (g) of the Act: None birth control cause constipationWeb2 days ago · Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks Cytokinetics (CYTK) declines 20% in the year so far as it suffers a regulatory setback for its NDA for omecamtiv mecarbil. 20h ago birth control cause hair loss